Literature DB >> 22634909

Surgical treatment of patients with penetrating chest injuries sustained in war.

Jozo Kristek1, Krunoslav Sego, Borislav Has.   

Abstract

AIM: To show our experience in treatment of patients with penetrating chest injuries sustained during the Homeland War in Croatia
METHODS: It was a retrospective study based on the records of the Department of Surgery of the University Hospital of Osijek (Croatia). All patients surgically treated during the wartime period (1991.-1995.) were analysed with respect to death rate, causes of injuries, frequency of injuries of thoracic organs and frequency of combined injuries of thorax and abdomen. Most of our patients were treated with thoracotomy as opposed to the common protocol (thoracostomy) applied in usual treatments.
RESULTS: The study includes 157 patients with penetrating chest wounds, 111 (70.7%) of which were from metal fragments of bursting artillery, 37 (23.6%) of the wounded were exposed to gunshot bullets, and 9 (5.7%) had stab injuries. Lung injuries had 134 (85.4%) patients, and 15 (9.6%) had injuries of the heart. Chest injuries combined with injuries of abdominal organs happened in 30 (19%) cases. The abdominal organs in question were the liver, spleen, stomach, and colon, in eight (26.6%), seven (23.3%), four (13.3%), and three (10.0%) cases, respectively. Thoracotomy was performed in 144 (91.7%) cases, 13 (8.3%) of the patients underwent thoracostomy, and 134 (85.3%) patients stayed alive.
CONCLUSIONS: It points out that, in our case due to organizational problems, aggressive surgical procedure of patients with penetrating chest and multiple injuries sustained in war was the good choice.

Entities:  

Mesh:

Year:  2012        PMID: 22634909

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

1.  Curative effect of pleural lavage on open chest trauma caused by seawater immersion.

Authors:  Bing Chen; Zhong-Yuan Lu; Jun Zhang; Zhen Zhu; Xiong-Wei Li
Journal:  Ann Saudi Med       Date:  2013 May-Jun       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.